[198 Pages Report] The 3D printing medical devices market is projected to grow from an estimated USD 0.84 billion in 2017 to USD 1.88 billion by 2022, at a CAGR of 17.5% during the forecast period. Market growth is largely driven by factors such as technological advancements, increasing public-private funding for 3D printing activities, easy development of customized medical products, and growing applications in the healthcare industry.

By component, the 3D printed equipment segment is expected to grow at the highest rate during the forecast period

On the basis of components, the 3D printing medical devices market is segmented into software & services, equipment (3D printers and 3D bioprinters), and materials (plastics, metal & metal alloys powder, bioprinting biomaterials, and others). In 2017, the software & services segment accounted for the largest share of the 3D printing medical devices market. Whereas, the 3D printing equipment segment is poised to witness the highest growth rate during the forecast period.

By technology, the photopolymerization segment was the largest contributor to the 3D printing medical devices market in 2017

Based on technology, the global 3D printing medical devices market is segmented into five broad categories, namely, electron beam melting, laser beam melting, photopolymerization, droplet deposition (DD) or extrusion-based technologies, and three-dimensional printing (3DP) or adhesion bonding or binder jetting. The photopolymerization technology segment commanded the largest share of the global 3D printing medical devices market in 2017. This is attributed to the widespread application of this technology across the medical industry, for manufacturing surgical guides (orthopedic, dental, and CMF guides), prosthetics and implants, porous scaffolds, and dental restorations

The surgical guides segment was the largest contributor to the 3D-printed medical products market in 2017

By type, the 3D-printed medical products market is further segmented into four major categories, namely, surgical guides, surgical instruments, prosthetics & implants, and tissue engineering products. The surgical guides segment accounted for the largest share of the 3D printing medical devices market in 2017. The increasing use of the digitally driven process for accurate surgical planning is the key factor contributing to its market growth.

Asia Pacific is expected to grow at the highest CAGR in the 3D printing medical devices market during the forecast period

Geographically, the 3D printing medical devices market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW). The Asia Pacific is one of the major high growth revenue-generating regions in the 3D printing medical devices market. The establishment of new 3D printing research, training, and education centers, and rising efforts by leading market players for expanding their distribution networks in emerging Asian countries are factors propelling the growth of the 3D printing medical devices market in Asia-Pacific.

Market Dynamics

The 3D printing medical devices market is primarily driven by factors such as technological advancements, increasing public-private funding, easy development of customized medical products, and growing applications in the healthcare industry. On the other hand, factors such as the stringent regulatory process and the dearth of trained professionals are expected to limit market growth to a certain extent.

However, direct digital manufacturing, the reconfiguration of supply chain models of medical device manufacturers, the expiry of key patents in the coming years, and the growing demand for organ transplant are expected to provide growth opportunities for players in the market.

Driver:Technological advancements in 3D printing

Various companies are increasingly focusing on developing new 3D-printed products and technologies to cater to the growing demand for 3D printing in the healthcare industry. As traditional manufacturing processes are time-consuming and expensive, major companies are engaged in the development of novel products and technologies, which are affordable and less time-consuming.

Restraint : Stringent regulatory process for the approval of 3D-printed medical devices

Stringent regulatory guidelines (especially in the US) are a major factor restraining the growth of the 3D printing medical devices market. Simple 3D-printed devices receive FDA approval, but complex devices that need to comply with a large number of FDA requirements are a hurdle for the availability of 3D-printed products on a large scale. Moreover, state legal requirements and manufacturing regulations become an obstacle for dispensing 3D-printed medicines

Scope of the Report

Report Metric Details Market Size Available for Years 2015�2022 Base Year Considered 2016 Forecast Period 2017�2022 Forecast Units Value (USD) Segments Covered Technology, Component, Type, and Region Geographies Covered North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW (Latin America and Middle East) Companies Covered Stratasys Ltd. (Israel and US), 3D Systems Corporation (US), Materialise NV (Belgium), EnvisionTEC GmbH (Germany), EOS GmbH Electro Optical Systems (Germany), Renishaw plc (U.K.), Concept Laser GmbH (Germany), 3T RDP, Ltd. (UK), Prodways (France), Arcam AB (Sweden), Anatomics Pty Ltd (Australia), Biomedical Modeling Inc. (US), Carbon, Inc. (US), SLM Solutions Group AG (Germany), Organovo Holdings, Inc. (US) . Major 15 players covered.

This research report categorizes the 3D printing medical devices market as follows:

3D Printing Medical Devices Market, by Component

Equipment

3D Printers

3D Bioprinters

Materials

Plastics

Thermoplastics

Photopolymers

Metal and Metal Alloys Powder

Biomaterials

Others

Ceramic

Paper

Wax

Software & Services

3D Printing Medical Devices Market, by Technology

Electron Beam Melting (EBM) Technology

Laser Beam Melting (LBM) Technology

Direct Metal Laser Sintering (DMLS)

Selective Laser Melting (SLM)

Selective Laser Sintering (SLS)

LaserCUSING

Photopolymerization

Digital Light Processing

Stereolithography

Two-photon Polymerization

PolyJet Technology

Droplet Deposition (DD)/Extrusion-based Technologies

Low-temperature Deposition Manufacturing (LDM)

Multiphase Jet Solidification (MJS)

Fused Deposition Modelling (FDM)

Three-dimensional Printing (3DP)/Adhesion Bonding/Binder Jetting

3D-Printed Medical Products Market, by Type

Surgical Guides

Dental Guides

Craniomaxillofacial Guides

Orthopedic Guides

Surgical Instruments

Retractors

Scalpels

Surgical Fasteners

Prosthetics and Implants

Standard Implants

Custom Implants

Custom Orthopedic Implants

Custom Dental Implants

Custom Craniomaxillofacial Implants

Tissue Engineering Products

3D Printing Medical Devices Market, by Region

North America U.S. Canada

Europe Germany France U.K. Rest of Europe

Asia-Pacific Japan China India Rest of Asia-Pacific

Rest of the World Latin America Middle East & Africa



Key Market Players

Stratasys Ltd. (Israel and US), 3D Systems Corporation (US), Materialise NV (Belgium), EnvisionTEC GmbH (Germany), EOS GmbH Electro Optical Systems (Germany), Renishaw plc (UK), Concept Laser GmbH (Germany), 3T RDP, Ltd. (UK), Prodways (France), Arcam AB (Sweden), Anatomics Pty Ltd (Australia), Biomedical Modeling Inc. (US), Carbon, Inc. (US), and SLM Solutions Group AG (Germany), Organovo Holdings, Inc. (US), among others

Stratasys Ltd. (Israel & US) held the leading position in the global 3D printing medical devices market in 2016. The company�s 3D printing product portfolio includes a wide range of 3D printing systems and consumables through which it caters to the demand of various industries, including automotive, consumer electronics, aerospace, dental, defense, education, commercial products, architecture, and medical. The company also offers services associated with its 3D printing products. The company primarily focuses on product innovation and new product launches as its key business strategy to sustain its leadership position in the global 3D printing medical devices market.

3D Systems Corporation (US) held the second position in the 3D printing medical devices market in 2016. The company incorporates a broad range of 3D printing solutions in its product portfolio, comprising desktop 3D printers, print materials, cloud-sourced custom parts, and 3D digital design and fabrication solutions. The company primarily focuses on expanding its 3D printing product portfolio in order to increase its share in the global 3D printing medical devices market.

Recent Developments:

In 2017, 3D Systems Corporation (US) launched the Simbionix SPINE Mentor

In 2017, Renishaw plc (UK) entered into a partnership with London Medical Network (Canada) and Western University (Canada) to focus on research, development, and commercialization of additively manufactured medical devices and surgical instruments

In 2017, Materialise NV (Belgium) partnered with a number of medical professionals across the US, with the aim to improve outcomes, enhance costly trials, and help these professionals to bring innovations in the 3D printing industry

Key Questions Addressed by the Report:

What are the growth opportunities related to the adoption of 3D printing medical devices across major regions in the future?

Emerging countries have immense opportunities for the growth and adoption of 3D printing medical devices. Will this scenario continue in the next five years?

Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?

What will be the impact of artificial intelligence on 3D printing?

What are the new trends and advancements in the 3D printing medical devices market? Are there any new products being developed for 3D printing in the medical industry?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst